Restrictions for patents owners to preserve the public interest in the sufficient availability of necessary medicinal products
GDPR and life sciences – part 2
The Bolar and related exemptions in Europe
What activity do they cover?
by multiple authors
Falsified Medicine Directive continued: Safety features on medicinal products and its consequences
GDPR and private sector life sciences
by Debbie Heywood and Sally Annereau
National perspectives on the CJEU Bayer decision
by multiple authors
Global Data Hub - life sciences
by multiple authors
Synapse - December 2019
by multiple authors
First Dutch GDPR fine for failing to ensure security of patient files
Dr Bill Frankland: Penicillin, the pollen count and perspectives on medicine